Exicure, Inc. Announces Adjournment of Annual Meeting of Stockholders
apnews.com
business
2022-05-27 20:03:01

CHICAGO--(BUSINESS WIRE)--May 27, 2022--Exicure, Inc. (NASDAQ: XCUR), an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting RNA to address both genetic and non-genetic neurological disorders and hair loss disorders, today announced that the Company's Annual Meeting of Stockholders (the 'Annual Meeting') held in virtual format on Friday, May 27, 2022 at 1:00 p.m. Central Time, was convened and adjourned until June 10, 2022 at 1:00 p.m. Central Time without any business being conducted.
